Yearly Archives: 2015

/2015

CEPOP Lunch Briefing – Innovations to Address Prescription Drug Abuse

Join CEPOP on Thursday, December 3 at the Capitol Visitors Center to learn how precision medicine, big data, disposal technology, new therapies,  and other innovative approaches are helping to confront the opioid abuse epidemic. The lunch is from 11:30 to 1 p.m. The full invitation can be found here.

2016-07-11T17:42:20+00:00December 2nd, 2015|News|

Press Release Supports White House Action

CEPOP issued the attached press release (CEPOP October 2015 Press Release White House Action) commending the White House for its efforts to address the ongoing opioid epidemic as well as its recognition of private sector efforts to do the same.

2016-07-11T17:41:57+00:00October 30th, 2015|Press Releases|

CEPOP Leader Talks to Chairman Upton as Subcommittee Hearing Unfolds

CEPOP co-founder Mary Bono sat down with House Energy & Commerce Committee Chairman Upton to discuss the current policy landscape surrounding prescription opioid abuse. The meeting came as the E&C Health Subcommittee was reviewing several legislative proposals to address different dimensions of the epidemic.

2016-07-11T17:42:25+00:00October 30th, 2015|News|

CEPOP Participants Meet with CDC Director Frieden on FY 2017 Agency Plan and Proposed Prescription Guidelines

Last month, CEPOP members met with CDC Director Dr. Tom Frieden to discuss the agency’s unfolding FY 2017 initiatives, and to learn more about the CDC’s draft guidelines for prescribing opioids for chronic pain.  CEPOP will continue advocacy for the final FY 2017 appropriations and will develop comments on the proposed guidelines.

2016-07-11T17:42:31+00:00October 30th, 2015|News|

Journal of the American Medical Association Highlights Opioid Issue

October issue, the JAMA published a series of articles on the growing opioid epidemic, demonstrating the range issues facing the medical community and policymakers. The articles included Addressing the Opioid Epidemic, Changes in Substance Abuse Treatment Use, and Nonmedical Prescription Opioid Use.

2016-07-11T17:42:36+00:00October 30th, 2015|News|

Study on Florida’s PDMP and Pill Mill Laws

In a recent study, researchers found a correlation between Florida’s Prescription Drug Monitoring Program (PDMP) and pill mill laws and a decrease in opioid prescribing and use, particularly among patients with the highest levels of use.

2016-07-11T17:42:48+00:00September 9th, 2015|News|

House Passes H.R. 1462 – Protecting Our Infants Act of 2015

The House yesterday passed the Protecting Our Infants Act of 2015, which now moves on to the Senate for consideration. Sponsored by Rep. Katherine Clark (MA-D-5), this bill would mandate an evaluation of the rise of prenatal opioid abuse and neonatal abstinence syndrome and include recommendations for prevention and treatment.

2016-07-11T17:41:40+00:00September 9th, 2015|News|

House Democrats write to FDA

House Energy & Commerce Committee Democrats wrote to U.S. FDA Commissioner Ostroff requesting his agency require opioid manufacturers to revise their product labels to reflect concerns surrounding neonatal abstinence syndrome. The letter was signed by 22 members.

2016-07-11T17:42:55+00:00August 14th, 2015|News|